Pregabalin controlled release, 330 mg

DRUG4 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions

Healthy

Phase 1

An Investigation of the Absorption and Pharmacokinetics of Multiple Doses of Three Controlled Release Pregabalin Tablets as Compared to Multiple Doses of the Immediate Release Pregabalin Capsule

CompletedNCT01009541

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Healthy

Start: 2009-11-30End: 2009-12-31Updated: 2021-01-22

An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule

CompletedNCT01202422

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Healthy

Start: 2010-10-31End: 2010-11-30Updated: 2021-01-22

An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers

CompletedNCT01257516

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Healthy

Start: 2011-02-28End: 2011-03-31Updated: 2021-01-22

An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet

CompletedNCT01342198

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Healthy

Start: 2011-06-30End: 2011-07-31Updated: 2021-01-22